CVS Health (NYSE:CVS) Stock Rating Cut to “Buy” at Wall Street Zen

Wall Street Zen downgraded shares of CVS Health (NYSE:CVS) from a strong-buy rating to a buy rating in a research report report published on Saturday morning,Wall Street Zen reports.

A number of other brokerages also recently issued reports on CVS. Wells Fargo & Company boosted their price target on CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a report on Monday, July 13th. HSBC reiterated a “hold” rating and issued a $103.00 price objective on shares of CVS Health in a report on Monday, July 6th. BMO Capital Markets set a $112.00 price objective on CVS Health in a research report on Wednesday, September 9th. Royal Bank Of Canada boosted their target price on CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Finally, JPMorgan Chase & Co. raised their price target on CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Twenty-two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $107.24.

CVS Health Trading Up 1.4%

Shares of CVS opened at $86.40 on Friday. The stock has a market capitalization of $110.50 billion, a P/E ratio of 22.86, a PEG ratio of 0.84 and a beta of 0.60. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The firm has a fifty day simple moving average of $94.68 and a two-hundred day simple moving average of $91.90. CVS Health has a twelve month low of $69.51 and a twelve month high of $110.68.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. The business had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company’s revenue was up 7.3% on a year-over-year basis. During the same quarter last year, the firm earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, research analysts anticipate that CVS Health will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd will be given a dividend of $0.6650 per share. This represents a $2.66 annualized dividend and a yield of 3.1%. The ex-dividend date of this dividend is Thursday, October 22nd. CVS Health’s payout ratio is presently 70.37%.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in CVS. Kilter Group LLC purchased a new stake in CVS Health in the second quarter worth $27,000. Beaird Harris Wealth Management LLC boosted its holdings in shares of CVS Health by 201.0% during the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 195 shares in the last quarter. J.Safra Asset Management Corp bought a new stake in shares of CVS Health during the 2nd quarter valued at $30,000. Timbuktu Capital Management LLC purchased a new stake in shares of CVS Health in the 2nd quarter worth about $31,000. Finally, Dunhill Financial LLC bought a new position in shares of CVS Health in the 2nd quarter worth about $32,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corp. is an integrated health care company that provides pharmacy, insurance and health services primarily in the United States. Its operations are designed to connect consumers, health plans, health care providers and pharmacy services across multiple points of care.

The company’s major businesses include CVS Pharmacy retail locations, prescription fulfillment and consumer health products; CVS Caremark, a pharmacy benefit management business; and Aetna, which offers health insurance products and related services for employers, individuals, government programs and other organizations.